excess supply. These factors affect the sales volume and selling price. Therefore has a direct impact on the company's gross profit and net profit. Moreover, the Company and its subsidiaries have set aside
Liabilities Total Shareholder Equity Million Baht 31-Mar-20 31-Dec-19 7 5. KEY FINANCIAL RATIOS 1Q'20 2019 Return on Equity 13.7% 15.5% Debt/Equity Ratio 1.19x 0.95x Net Interest-bearing Debt/Equity Ratio 0.86x
contracts and gain from the disposal of ordinary shares in joint venture companies • EBITDA stood at THB 33mn (down 74.9% YoY) largely as a result of the increase in unrealised loss on exchange rate. EBITDA
consumption, production and export sectors in Thailand. There are various industries that have an impact on the production and supply chain from upstream to their downstream, such as electricity, electronics
beginning of this year, the Company had gain on exchange rate while the Thai Baht value appreciated against US Dollar and the Company had loss on exchange rate in last year As a result of above reason, the
lockdown in many countries around the world including Thailand. But the negative impact on domestic consumption, manufacturing and export sectors persisted in this quarter, despite improvement from the
to the same period of the previous year. The main reasons was the weaken sales due to the impact of trade wars that have the broad impact on global supply chain and through Thailand's exports. As such
-emerged and further strained tension on economy. Competition around data pricing with unlimited plan remained high and barred monetizing rise in data demand as well as stabilizing ARPU. However, mobile
Saimai Avenue branch, PTT Pattanakarn gas station branch, and PTT Rama 2 gas station branch. As a result, in Q2/2022, there were all together 4 After You Marketplace standalone branches. Focus on Expanding
services. This is in line with changing consumer behavior after the COVID-19 outbreak. 2023 Outlook Perspective on the Recovery After the Easing of COVID-19 Measures Presently, the situation of the COVID-19